Japanese Trade Distributors Stock News

Sharp (TSE:6753) is drawing new attention after launching its first health-focused smartwatch, the Karada Mate Watch. The device uses HEALBE’s FLOW technology to automatically estimate calorie intake, hydration, and other physiological metrics. See our latest analysis for Sharp. Despite the Karada Mate Watch signalling a new push into digital health wearables, Sharp’s share price return tells a mixed story, with the stock down 18.75% year to date and up 6.9% over 90 days, while the 1 year...

Japan’s consumer goods and retail giants are sitting at the crossroads of two powerful forces: potential policy shifts from the Bank of Japan and global demand tied to AI and electronics. With rates holding at 1% for now and inflation pressures still on the BOJ’s radar, pricing power, cost control, and exposure to import costs all matter more for Japanese Consumer Goods and Retail stocks. This article explains how that backdrop connects to our screener and highlights 3 stocks that appear...

Ajinomoto Co., Inc. and the University of Tokyo recently reported that their jointly developed ANPS-Day system can assess a full day’s diet quality using biomarkers from healthy Japanese adults, marking a Japan-first link between real-world dietary data and 24-hour urine collection results. This scientific validation strengthens Ajinomoto’s position in health-oriented food technologies, potentially enhancing the credibility and differentiation of its nutrition-focused products and...

In July 2026, Custom Market Insights published a report projecting the global lithium-ion battery market to reach about US$468.50 billion by 2035, with Panasonic Holdings highlighted among the key industry participants benefiting from government-backed energy storage and electric vehicle demand. The report also points to Asia Pacific’s current leadership and very large expected growth in North America, underscoring how regional policy support could be especially important for manufacturers...

In recent weeks, global markets have shown mixed performances, with major U.S. indices like the Nasdaq Composite and S&P 500 advancing, while small-cap focused indices such as the Russell 2000 have seen declines amid a cooling labor market and subdued consumer confidence. As investors navigate these complex conditions, identifying promising small-cap stocks requires focusing on companies that demonstrate resilience through strong fundamentals and potential for growth in niche markets.

As global markets navigate mixed signals from economic data and sector-specific performances, investors are paying close attention to dividend stocks as a potential source of stability amid uncertainty. In this environment, a good dividend stock is often characterized by consistent payouts and strong fundamentals, offering investors the potential for steady income even when broader market conditions are volatile.

CG Semi Private Limited, a joint venture between CG Power and Industrial Solutions, Renesas Electronics Corporation, and Stars Microelectronics, has begun commercial production at its G1 Outsourced Semiconductor Assembly and Test facility in Sanand, which was inaugurated in August 2025 and is designed for up to 300 million units per year. This launch marks a meaningful expansion of outsourced assembly and test capacity backed by over ₹76.00 billion of planned investment across two...

It's been a mediocre week for NEXTAGE Co., Ltd. ( TSE:3186 ) shareholders, with the stock dropping 11% to JP¥3,605 in...

The recent earnings posted by Daido Steel Co., Ltd. ( TSE:5471 ) were solid, but the stock didn't move as much as we...

In recent trading, Ono Pharmaceutical reported progress across its oncology and specialty medicine portfolio, including regulatory advances for Opdivo, expanded development of Velexbru, positive mid-stage data for ONO-4578 and ONO-2808, and a regulatory filing for Qinlock in Japan. These developments, alongside the launch of newer products like Romvimza and a broader rare disease and cancer portfolio, highlight Ono’s effort to diversify revenue sources beyond a single blockbuster...

As global markets navigate a landscape marked by mixed economic signals and sector rotations, the Asian market remains a focal point for investors seeking growth opportunities. In this context, companies with high insider ownership often stand out as they can indicate strong confidence from those closest to the business, potentially aligning well with current market dynamics that favor resilient and committed leadership.

As global markets navigate a period of mixed economic signals and sector rotations, Asian equities have shown resilience, particularly in the manufacturing and financial sectors. In this environment, dividend stocks can offer investors a stable income stream while potentially benefiting from Asia's ongoing economic developments.

Japan’s rate market has swung sharply back into focus, with the 10 year government bond yield hitting 2.88% and renewed concern over inflation, oil prices, and heavy fiscal spending. For investors, this mix of higher yields and inflation risk can quietly reshape which stocks look resilient and which ones may struggle. This article looks at three stocks exposed to the latest news on Japanese rates and inflation pressures, all on the risk side of the ledger, to help you spot where rising...

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Japan’s 10-year bond yield sitting at 2.825%, the highest level since 1996, is forcing investors to rethink how to position around domestic financial stocks. With the Bank of Japan trimming its bond purchases, heavier government bond issuance ahead, a weak yen and pressure on crowded yen carry trades, the ripple effects across banks and insurance companies could be significant. This article focuses on how these shifts may affect Japanese financials and highlights 3 stocks from our Domestic...

As of July 2026, the Asian markets are navigating a complex landscape marked by mixed returns in major indices and evolving economic indicators. With China's manufacturing activity showing resilience and Japan's business sentiment improving, investors are keenly observing small-cap opportunities that may thrive amid these broader market dynamics. In this context, identifying stocks with strong fundamentals and growth potential becomes crucial for those seeking to capitalize on Asia's diverse...

Resona Holdings (TSE:8308) has launched two unsecured yen bond issues totaling ¥70 billion and completed a share repurchase of 10,026,200 shares, drawing attention to how the bank is managing its capital structure. See our latest analysis for Resona Holdings. The recent bond issuance and completed share buyback arrive at a time when Resona Holdings’ share price has strong momentum, with a 7 day share price return of 11.52% and a year to date share price return of 51.79%. The 1 year total...

Japan’s sovereign debt stress is back in focus as 10‑year government bond yields touch 2.87% and questions build around a $2.3tn spending plan. For investors, that combination of higher yields, a weaker yen and concern about long term fiscal sustainability can reshape the risk profile of Japan’s financial sector. Some stocks may be positioned to benefit, but others face pressure as funding costs and bond market volatility bite. This article looks at 3 Japanese financial stocks that appear...

Ecowende announced that its 760MW Hollandse Kust West offshore wind farm in the Netherlands, developed by a joint venture including Chubu Electric Power, has been connected to TenneT's offshore grid and has already delivered its first green electricity. This milestone highlights Chubu Electric Power's growing participation in large-scale international renewable projects, underlining its role in the broader energy transition. With the Hollandse Kust West project now feeding power into the...

Ono Pharmaceutical (TSE:4528) moved sharply on the back of regulatory progress for Opdivo, pipeline updates around Velexbru and Qinlock, and encouraging mid stage trial data that reinforced interest in its cancer and rare disease portfolio. See our latest analysis for Ono Pharmaceutical. Against this backdrop, Ono Pharmaceutical’s share price has a 10.5% 1 month share price return and a 12.3% year to date share price return, while its 1 year total shareholder return of 65.0% points to strong...

Sales update puts Kyoritsu Maintenance in focus Kyoritsu Maintenance (TSE:9616) has drawn fresh attention after reporting preliminary sales for May 2026 and the year to date, with both figures higher than the same periods a year earlier. See our latest analysis for Kyoritsu Maintenance. The recent sales update has arrived alongside a strong run in Kyoritsu Maintenance's share price, with a 30 day share price return of 24.43% and a 90 day share price return of 22.27%. This comes even though...

Key earnings guidance figures investors are watching BANDAI NAMCO Holdings (TSE:7832) recently issued new earnings guidance, outlining expectations for the six months ending September 30, 2026, and the full fiscal year ending March 31, 2027, giving investors fresh visibility on projected results. For the first half of the fiscal year, the company is guiding to net sales of ¥610,000 million, operating profit of ¥84,000 million, profit attributable to owners of parent of ¥60,000 million, and...

The start of commercial production at CG Semi’s G1 OSAT facility in Gujarat puts Renesas Electronics (TSE:6723) in focus, as investors assess what this new India based capacity could mean for the stock. See our latest analysis for Renesas Electronics. Recent trading reflects this backdrop, with Renesas Electronics’ share price at ¥4,744, a 90 day share price return of 81.69% and a 1 year total shareholder return of 152.43%, suggesting strong momentum rather than a short term spike. If you are...

EXEO Group (TSE:1951) has completed the share repurchase program announced on February 6, 2026, buying back 1,425,100 shares for ¥3,999.56 million. Recent governance votes kept the existing board lineup unchanged. See our latest analysis for EXEO Group. At a share price of ¥2,737.0, EXEO Group’s 1 year total shareholder return of 52.41% and 5 year total shareholder return of 137.34% point to strong longer term momentum, even though the 30 day share price return declined 3.30% following the...